Skip to content

Skeletal Muscle Mass on Prognosis and Recovery in Clinical Trial

Comprehensive Interpretation of the Importance of Skeletal Muscle Mass on Prognosis and Recovery in Cardiac Arrest Survivors: From Machine Learning to Clinical Trial

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07034170
Enrollment
90
Registered
2025-06-24
Start date
2025-06-01
Completion date
2028-12-31
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inhospital Cardiac Arrest, Out of Hospital Cardiac Arrest

Keywords

cardiac arrest, Skeletal muscle mass, rehabilitation

Brief summary

The objective of this research project is to develop an automated muscle mass measurement system based on computed tomography (CT) images using deep learning and artificial intelligence, and to construct a prognostic prediction model for patients who have experienced cardiac arrest and undergone resuscitation. The model will be validated using multicenter registry data and medical imaging. Furthermore, a clinical trial involving core muscle rehabilitation for post-resuscitation patients will be conducted to evaluate both short-term and long-term outcomes, aiming to comprehensively understand the impact of muscle mass on the prognosis of patients after cardiac arrest.

Interventions

BEHAVIORALEnhanced Rehabilitation Program

Participants in the intervention group receive an enhanced rehabilitation program, including muscular electrical stimulation, guided active rehabilitation sessions, and structured physical engagement during periods of consciousness. The intervention is designed to promote functional improvement in post-cardiac arrest patients.

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Intervention model description

This is a parallel assignment trial in which participants are allocated to study arms based on the month of admission. Patients admitted during even-numbered months are assigned to the intervention group, while those admitted during odd-numbered months are assigned to the control group.

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Non-traumatic adult patients who experienced sudden cardiac arrest * Achieved sustained return of spontaneous circulation (ROSC) for more than five minutes following successful resuscitation * Admitted to the ICU * Survived beyond 72 hours without successful weaning from mechanical ventilation

Exclusion criteria

* Age under 18 years * Pregnancy * Expected to be weaned from mechanical ventilation within 48 hours * Terminal-stage cancer or unwillingness to receive aggressive treatment * Unavailability of ICU care due to overcrowding in the emergency intensive care unit * Refusal to participate in the study by the patient or family members * Presence of an implanted pacemaker or defibrillator * Open wounds, severe edema, or deep vein thrombosis in the lower limbs * Pre-arrest status limited to wheelchair use or bedridden, unable to ambulate

Design outcomes

Primary

MeasureTime frameDescription
skeletal muscle mass21 daysMuscle changes were measured weekly using a handheld ultrasound.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 21, 2026